# Impact of Oral Versatile Antioxidants on Glaucoma Progression

> **NCT01544192** · PHASE3 · COMPLETED · sponsor: **Bagcilar Training and Research Hospital** · enrollment: 60 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Gingko Biloba
- **DRUG:** α-tocopherol
- **DRUG:** Placebo
- **DRUG:** Antioxidant formula

## Key facts

- **NCT ID:** NCT01544192
- **Lead sponsor:** Bagcilar Training and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-11
- **Final completion:** 2012-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2012-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01544192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01544192, "Impact of Oral Versatile Antioxidants on Glaucoma Progression". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01544192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*